ID   TihoDProTCC1509
AC   CVCL_ZV60
SY   DT15/09; TCC1509
DR   GEO; GSM5720824
DR   GEO; GSM5720825
DR   GEO; GSM5720826
DR   GEO; GSM5720827
DR   GEO; GSM5720828
DR   GEO; GSM5720829
DR   GEO; GSM5720830
DR   GEO; GSM5720831
DR   GEO; GSM5720832
DR   GEO; GSM5720833
DR   GEO; GSM5720834
DR   GEO; GSM5720835
DR   Wikidata; Q98133262
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 19.9 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Bolonka Zwetna; VBO=VBO_0201147.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
RX   PubMed=32168360; DOI=10.1371/journal.pone.0230272; PMCID=PMC7069630;
RA   Packeiser E.-M., Hewicker-Trautwein M., Thiemeyer H., Mohr A.,
RA   Junginger J., Schille J.T., Murua Escobar H., Nolte I.;
RT   "Characterization of six canine prostate adenocarcinoma and three
RT   transitional cell carcinoma cell lines derived from primary tumor
RT   tissues as well as metastasis.";
RL   PLoS ONE 15:e0230272.1-e0230272.25(2020).
//
RX   PubMed=35109825; DOI=10.1186/s12935-021-02422-9; PMCID=PMC8812184;
RA   Packeiser E.-M., Taher L., Kong W.-B., Ernst M., Beck J.,
RA   Hewicker-Trautwein M., Brenig B., Schutz E., Murua Escobar H.,
RA   Nolte I.;
RT   "RNA-seq of nine canine prostate cancer cell lines reveals diverse
RT   therapeutic target signatures.";
RL   Cancer Cell Int. 22:54.1-54.21(2022).
//